AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 122 min read$BFLY

DEVIVO JOSEPH sold $684K of BFLY

DEVIVO JOSEPH (President & CEO) sold 68,346 shares of Butterfly Network, Inc. (BFLY) at $10.01 ($0.68M total) on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DEVIVO JOSEPH
Published Aug 12, 2026, 8:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
medium confidence
Mentioned
$BFLY
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

The only new information is the CEO’s executed open-market sale details and the confirmation that it was under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor insider activity as a sentiment input, but this filing alone does not provide a new fundamental catalyst for BFLY.

03

What to watch

The filing does not state whether other insiders or the company made offsetting purchases, nor does it provide context on total insider ownership changes beyond the post-transaction share count.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-12, sale executed 2026-08-10

Background

The article is an SEC Form 4 insider transaction disclosure for Butterfly Network, Inc.

Company-level read

Ticker impact

$BFLYNeutralMedium confidence
Context

SEC Form 4 shows CEO Devivo Joseph sold 68,346 shares of Butterfly Network at $10.0090 on 2026-08-10 under a 10b5-1 plan.

Expected impact

Low near-term impact; any reaction is likely limited to sentiment around insider selling.

Evidence & confidence

The article provides only the mechanics of an open-market sale by the CEO, explicitly under a pre-arranged 10b5-1 plan, with no accompanying guidance, contract, or regulatory development.

Market effects

Sector

Minimal. Insider-sale disclosures typically do not reset sector expectations without additional company-specific catalysts.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity needs rather than bearish information, so any negative read-through could be overstated.

Key entities

  • issuer
    Butterfly Network, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • insider
    DEVIVO JOSEPH

    President and CEO who executed the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BFLY insider trading history →

Related articles

OCT 12
$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

investorplace.com3 min
OCT 12
$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

investing.com2 min
SEP 29
$BFLYHigh

Evercore ISI initiates Butterfly Network stock with outperform rating

Evercore ISI initiated coverage on Butterfly Network (NYSE: BFLY) with an outperform rating and $15.00 price target, citing its ultrasound-on-chip technology and growth potential. The firm projects $550M+ revenue by 2030 and positive EBITDA by 2028. BFLY stock has risen 367% over the past year, trading at $9.15 with a $2.44B market cap. Q2 2026 results showed a smaller loss than expected but lower revenue. Needham also initiated coverage with a buy rating and $10.00 target.

investing.com2 min
SEP 22
$BFLYHighAI 8/10

Why is Butterfly Network stock surging today?

Butterfly Network (BFLY) stock rose 11.5% after Needham initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and Embedded business model. TD Cowen also has a Buy rating and $10 target. BFLY's Q3 revenue grew 39% YoY, with Embedded segment growth and expanding margins. The broader market had minimal impact on BFLY's surge.

investing.com2 min
SEP 15
$BFLYMed

Butterfly Network at Morgan Stanley conference: platform push widens reach

Butterfly Network (BFLY) presented its strategy at Morgan Stanley's conference, shifting from handheld ultrasound to a semiconductor imaging platform. The company reported 20% revenue growth, with $112M in last 12-month revenue, and highlighted partnerships like Midjourney. It aims to expand its addressable market to $250B through its Butterfly Embedded model. The company expects a fourth-generation chip in 2027 to improve image quality and challenge competitors. Management emphasized its strong

investing.com2 min